Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography.

[1]  C. Halldin,et al.  Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain. , 1998, Journal of clinical psychopharmacology.

[2]  D. Kupfer,et al.  Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging , 1998, Neuropsychopharmacology.

[3]  Marie-Laure Paillère-Martinot,et al.  No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET , 1998, Schizophrenia Research.

[4]  S. Kapur,et al.  A new framework for investigating antipsychotic action in humans: lessons from PET imaging , 1998, Molecular Psychiatry.

[5]  J. Joyce,et al.  Alterations in the cortical serotonergic system in schizophrenia: A postmortem study , 1997, Biological Psychiatry.

[6]  T Suhara,et al.  Possible role of dopamine D1 receptors in schizophrenia , 1997, Molecular Psychiatry.

[7]  M. Iyo,et al.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.

[8]  G. Busatto,et al.  Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia , 1997, Journal of psychopharmacology.

[9]  Paul J. Harrison,et al.  5-HT1A and 5-HT2A Receptor mRNAs and Binding Site Densities Are Differentially Altered in Schizophrenia , 1996, Neuropsychopharmacology.

[10]  B. Dean,et al.  Decreased frontal cortical serotonin2A receptors in schizophrenia , 1996, Schizophrenia Research.

[11]  Paul J. Harrison,et al.  The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain , 1996, Neuroscience.

[12]  S. Kapur,et al.  Serotonin-dopamine interaction and its relevance to schizophrenia. , 1996, The American journal of psychiatry.

[13]  J. Hietala,et al.  Differential Regulation of Rat 5-HT2A and 5-HT2C Receptors after Chronic Treatment with Clozapine, Chlorpromazine and Three Putative Atypical Antipsychotic Drugs , 1995, Neuropsychopharmacology.

[14]  G. Sedvall,et al.  D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. , 1995, The American journal of psychiatry.

[15]  F. Shishido,et al.  Hypersensitivity of cortical muscarinic receptors in Parkinson's disease demonstrated by PET , 1995, Acta neurologica Scandinavica.

[16]  A. Breier.  Serotonin, schizophrenia and antipsychotic drug action , 1995, Schizophrenia Research.

[17]  H. Meltzer.  The Role of Serotonin in Schizophrenia and the Place of Serotonin‐Dopamine Antagonist Antipsychotics , 1995, Journal of clinical psychopharmacology.

[18]  C. Halldin,et al.  Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients. , 1995, Journal of clinical psychopharmacology.

[19]  J. Kleinman,et al.  Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. , 1993, Archives of general psychiatry.

[20]  C Crouzel,et al.  Ligands and tracers for PET studies of the 5-HT system--current status. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[21]  C. Halldin,et al.  Comparison of the In Vitro Receptor Binding Properties of N‐[3H]Methylspiperone and [3H]Raclopride to Rat and Human Brain Membranes , 1990, Journal of neurochemistry.

[22]  H. Meltzer,et al.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.

[23]  P S Goldman-Rakic,et al.  Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. M. Szczepanik,et al.  Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain , 1989, Brain Research.

[25]  J. Palacios,et al.  Serotonin receptors in the human brain—IV. Autoradiographic mapping of serotonin-2 receptors , 1987, Neuroscience.

[26]  M. Kuhar,et al.  In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors. , 1987, Life sciences.

[27]  M. Ticku,et al.  Central cardiovascular effects of baclofen in spontaneously hypertensive rats. , 1987, Life sciences.

[28]  T. Kuno,et al.  Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics , 1986, Biological Psychiatry.

[29]  J M Links,et al.  3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  J. Leysen,et al.  Drug‐receptor dissociation time, new tool for drug research: Receptor binding affinity and drug‐receptor dissociation profiles of serotonin‐S2, Dopamine‐D2, histamine‐H1 antagonists, and opiates , 1986 .

[31]  H. Meltzer,et al.  Differential Effect of Subchronic Treatment with Various Neuroleptic Agents on Serotonin2 Receptors in Rat Cerebral Cortex , 1986, Journal of neurochemistry.

[32]  M. Martres,et al.  Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. , 1985, Science.

[33]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[34]  S. Tang,et al.  Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain , 1984, Psychiatry Research.

[35]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[36]  H. Meltzer,et al.  Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof. , 1984, Life sciences.

[37]  J. Maloteaux,et al.  Characterization and regional distribution of serotonin S2-receptors in human brain , 1983, Brain Research.

[38]  T. Crow,et al.  Tritiated LSD binding in frontal cortex in schizophrenia. , 1981, Archives of general psychiatry.

[39]  S. Snyder,et al.  Neurotransmitter receptors in frontal cortex of schizophrenics. , 1979, Archives of general psychiatry.

[40]  S. Kapur,et al.  Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects. , 1999, The American journal of psychiatry.

[41]  C. Halldin,et al.  PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  C. Halldin,et al.  A PET Study of 5-HT2 and D2 Dopamine Receptor Occupancy Induced by Olanzapine in Healthy Subjects , 1997, Neuropsychopharmacology.

[43]  S. Potkin,et al.  Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain , 1990, Synapse.